These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25979781)

  • 1. Newborn screening for spinal muscular atrophy: Anticipating an imminent need.
    Phan HC; Taylor JL; Hannon H; Howell R
    Semin Perinatol; 2015 Apr; 39(3):217-29. PubMed ID: 25979781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency.
    Taylor JL; Lee FK; Yazdanpanah GK; Staropoli JF; Liu M; Carulli JP; Sun C; Dobrowolski SF; Hannon WH; Vogt RF
    Clin Chem; 2015 Feb; 61(2):412-9. PubMed ID: 25502182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal muscular atrophy: newborn and carrier screening.
    Prior TW
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):23-36, Table of Contents. PubMed ID: 20494255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dried Blood Spot Screening System for Spinal Muscular Atrophy with Allele-Specific Polymerase Chain Reaction and Melting Peak Analysis.
    Wijaya YOS; Nishio H; Niba ETE; Shiroshita T; Kato M; Bouike Y; Tode C; Ar Rochmah M; Harahap NIF; Nurputra DK; Okamoto K; Saito T; Takeuchi A; Lai PS; Yamaguchi S; Shinohara M
    Genet Test Mol Biomarkers; 2021 Apr; 25(4):293-301. PubMed ID: 33877896
    [No Abstract]   [Full Text] [Related]  

  • 5. High-throughput genetic newborn screening for spinal muscular atrophy by rapid nucleic acid extraction from dried blood spots and 384-well qPCR.
    Czibere L; Burggraf S; Fleige T; Glück B; Keitel LM; Landt O; Durner J; Röschinger W; Hohenfellner K; Wirth B; Müller-Felber W; Vill K; Becker M
    Eur J Hum Genet; 2020 Jan; 28(1):23-30. PubMed ID: 31363188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating neonatal spinal muscular atrophy: A 21st century success story?
    Tizzano EF
    Early Hum Dev; 2019 Nov; 138():104851. PubMed ID: 31604576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal muscular atrophy: a time for screening.
    Prior TW
    Curr Opin Pediatr; 2010 Dec; 22(6):696-702. PubMed ID: 20829691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution melting (HRM) analysis as a feasible method for detecting spinal muscular atrophy via dried blood spots.
    Er TK; Kan TM; Su YF; Liu TC; Chang JG; Hung SY; Jong YJ
    Clin Chim Acta; 2012 Nov; 413(21-22):1781-5. PubMed ID: 22771969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newborn screening for spinal muscular atrophy in Osaka -challenges in a Japanese pilot study.
    Kimizu T; Ida S; Oki K; Shima M; Nishimoto S; Nakajima K; Ikeda T; Mogami Y; Yanagihara K; Matsuda K; Nishi E; Hasegawa Y; Nozaki M; Fujita H; Irie A; Katayama T; Okamoto N; Imai K; Nishio H; Suzuki Y
    Brain Dev; 2023 Aug; 45(7):363-371. PubMed ID: 36973114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic carrier screening for spinal muscular atrophy and spinal muscular atrophy with respiratory distress 1 in an isolated population in Israel.
    Basel-Vanagaite L; Taub E; Drasinover V; Magal N; Brudner A; Zlotogora J; Shohat M
    Genet Test; 2008 Mar; 12(1):53-6. PubMed ID: 18298318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a Pilot External Quality Assessment Scheme for Genetic Testing of Newborns with Spinal Muscular Atrophy.
    Wang W; Wu L; Hui Y; Du Y; Yang J; Jiang P; Gu M; He H; Qiu L; Zhang Z; Gao L; Lin C; Jiang J; He X; Miao J; Li Y; Luo Z; Zhang H; Liu Y; Li L; Li X; Gan X; Mou K; Liang H; Shi A; Zhou S; Huang X; Sun L; Wan T; Ji G; Tang K; Ye Q; Sun Z; Dai Z; Du Y; Wang X; Yang Y; Xiong H; Wang Z
    Clin Lab; 2024 May; 70(5):. PubMed ID: 38747911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study of population-based newborn screening for spinal muscular atrophy in New York state.
    Kraszewski JN; Kay DM; Stevens CF; Koval C; Haser B; Ortiz V; Albertorio A; Cohen LL; Jain R; Andrew SP; Young SD; LaMarca NM; De Vivo DC; Caggana M; Chung WK
    Genet Med; 2018 Jun; 20(6):608-613. PubMed ID: 29758563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal muscular dystrophy - a revisit of the diagnosis and treatment modalities.
    Srivastava G; Srivastava P
    Int J Neurosci; 2019 Nov; 129(11):1103-1118. PubMed ID: 31271088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newborn and carrier screening for spinal muscular atrophy.
    Prior TW; Snyder PJ; Rink BD; Pearl DK; Pyatt RE; Mihal DC; Conlan T; Schmalz B; Montgomery L; Ziegler K; Noonan C; Hashimoto S; Garner S
    Am J Med Genet A; 2010 Jul; 152A(7):1608-16. PubMed ID: 20578137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False Negative Carrier Screening in Spinal Muscular Atrophy.
    Butcher S; Smith M; Woodcock IR; Delatycki M; Ryan MM; Forbes R
    J Child Neurol; 2020 Mar; 35(4):274-277. PubMed ID: 31858866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon nanofiber-based multiplexed immunosensor for the detection of survival motor neuron 1, cystic fibrosis transmembrane conductance regulator and Duchenne Muscular Dystrophy proteins.
    Eissa S; Alshehri N; Abduljabbar M; Rahman AMA; Dasouki M; Nizami IY; Al-Muhaizea MA; Zourob M
    Biosens Bioelectron; 2018 Oct; 117():84-90. PubMed ID: 29890394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moving towards treatments for spinal muscular atrophy: hopes and limits.
    Wirth B; Barkats M; Martinat C; Sendtner M; Gillingwater TH
    Expert Opin Emerg Drugs; 2015 Sep; 20(3):353-6. PubMed ID: 25920617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opening the window: The case for carrier and perinatal screening for spinal muscular atrophy.
    Burns JK; Kothary R; Parks RJ
    Neuromuscul Disord; 2016 Sep; 26(9):551-9. PubMed ID: 27460292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal muscular atrophy carrier screening by multiplex polymerase chain reaction using dried blood spot on filter paper.
    Majumdar R; Rehana Z; Al Jumah M; Fetaini N
    Ann Hum Genet; 2005 Mar; 69(Pt 2):216-21. PubMed ID: 15720302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMA screening system using dried blood spots on filter paper: application of COP-PCR to the SMN1 deletion test.
    Kato N; Sa'Adah N; Ar Rochmah M; Harahap NI; Nurputra DK; Sato H; Sadewa AH; Astuti I; Haryana SM; Saito T; Saito K; Nishimura N; Nishio H; Takeuchi A
    Kobe J Med Sci; 2015 Jan; 60(4):E78-85. PubMed ID: 25791416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.